RCEL R&D Expenses

Avita Medical Inc · R&D Expenses

RCEL logo

RCEL R&D Expenses

Latest reported$5.08M
RCEL Quarterly R&D Expenses ($1.02M → $5.08M)
High-resolution chart · PNG

RCEL r&d expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Avita Medical Inc R&D Expenses — Quarterly (USD)
Period endingR&D Expenses (USD)
5,078,000
5,629,000
5,690,000
3,748,000
5,117,000
6,284,000
4,850,000
5,428,000
4,887,000
5,194,000
6,765,000
4,394,000
5,076,000
4,586,000
3,379,000
3,799,000
3,059,000
3,620,000
4,198,000
3,388,000
3,974,000
4,109,000
3,361,000
3,374,000
1,835,000
4,108,558
3,282,610
3,597,332
2,223,878
2,004,393
3,227,496
3,540,106
374,533
3,776,896
2,565,232
2,525,816
1,883,753
1,876,279
1,260,255
1,257,706
952,980
958,298
773,402
773,460
1,428,021
1,415,689
449,554
471,975
793,538
792,181
255,613
283,401
712,009
717,055
585,211
558,672
365,942
1,019,303
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.